BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Forkhead box M1 (FOXM1)

April 9, 2015 7:00 AM UTC

Patient sample and mouse studies suggest FOXM1 inhibitors could help treat precursor B cell ALL (B-ALL). FOXM1 transcript levels were higher in B-ALL cells from patients than in mature and precursor B...